(MAS) Masco - Ratings and Ratios
Plumbing, Fixtures, Paint, Hardware, Coatings
Dividends
| Dividend Yield | 1.96% |
| Yield on Cost 5y | 2.58% |
| Yield CAGR 5y | 13.66% |
| Payout Consistency | 55.9% |
| Payout Ratio | 30.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.2% |
| Value at Risk 5%th | 41.7% |
| Relative Tail Risk | -6.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.69 |
| Alpha | -34.75 |
| CAGR/Max DD | 0.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.446 |
| Beta | 0.958 |
| Beta Downside | 0.866 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.95% |
| Mean DD | 10.32% |
| Median DD | 9.10% |
Description: MAS Masco October 30, 2025
Masco Corporation (NYSE:MAS) manufactures and distributes a broad portfolio of home-improvement and building products across North America, Europe, and other international markets. Its two primary segments are Plumbing Products-covering faucets, shower systems, PEX tubing, and related brands such as Delta, Hansgrohe, and Moen-style private labels-and Decorative Architectural Products, which supplies paints, primers, specialty coatings, cabinet hardware, and bathroom accessories under brands like BEHR, KILZ, and Franklin Brass.
Recent company filings indicate FY 2023 revenue of roughly $9.8 billion, with the Plumbing Products segment contributing about 70 % of total sales and delivering an operating margin near 13 %, while the Decorative segment accounts for the remaining 30 % with margins around 9 %. Key macro drivers include the U.S. housing-starts cycle (which has been rising 3-4 % YoY in 2024) and sustained DIY spending, both of which tend to boost demand for Masco’s remodeling-focused product lines. Conversely, input-cost inflation for copper and resin, as well as potential supply-chain constraints, remain material risk factors that could compress margins.
For a deeper, data-driven valuation of MAS, the ValueRay platform provides granular financial models and scenario analysis worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (827.0m TTM) > 0 and > 6% of Revenue (6% = 455.8m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA -2.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.20% (prev 17.09%; Δ 1.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 1.01b > Net Income 827.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.61b) to EBITDA (1.27b) ratio: 2.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (211.0m) change vs 12m ago -3.21% (target <= -2.0% for YES) |
| Gross Margin 35.66% (prev 36.15%; Δ -0.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 143.2% (prev 148.8%; Δ -5.58pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.29 (EBITDA TTM 1.27b / Interest Expense TTM 101.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.53
| (A) 0.26 = (Total Current Assets 2.96b - Total Current Liabilities 1.58b) / Total Assets 5.31b |
| (B) -0.11 = Retained Earnings (Balance) -576.0m / Total Assets 5.31b |
| (C) 0.18 = EBIT TTM 938.0m / Avg Total Assets 5.30b |
| (D) -0.01 = Book Value of Equity -77.0m / Total Liabilities 5.14b |
| Total Rating: 2.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.19
| 1. Piotroski 6.0pt |
| 2. FCF Yield 5.45% |
| 3. FCF Margin 11.15% |
| 4. Debt/Equity -40.68 |
| 5. Debt/Ebitda 2.06 |
| 6. ROIC - WACC (= 16.35)% |
| 7. RoE -474.6% |
| 8. Rev. Trend -59.89% |
| 9. EPS Trend 35.94% |
What is the price of MAS shares?
Over the past week, the price has changed by -2.57%, over one month by +0.17%, over three months by -16.50% and over the past year by -19.91%.
Is MAS a buy, sell or hold?
- Strong Buy: 6
- Buy: 4
- Hold: 13
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the MAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.7 | 16.6% |
| Analysts Target Price | 73.7 | 16.6% |
| ValueRay Target Price | 61.9 | -2.1% |
MAS Fundamental Data Overview November 26, 2025
P/E Trailing = 15.7903
P/E Forward = 14.7059
P/S = 1.7015
P/B = 164.4201
P/EG = 1.4716
Beta = 1.273
Revenue TTM = 7.60b USD
EBIT TTM = 938.0m USD
EBITDA TTM = 1.27b USD
Long Term Debt = 2.94b USD (from longTermDebt, last quarter)
Short Term Debt = 2.00m USD (from shortTermDebt, last quarter)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.61b USD (from netDebt column, last quarter)
Enterprise Value = 15.54b USD (12.93b + Debt 3.17b - CCE 559.0m)
Interest Coverage Ratio = 9.29 (Ebit TTM 938.0m / Interest Expense TTM 101.0m)
FCF Yield = 5.45% (FCF TTM 847.0m / Enterprise Value 15.54b)
FCF Margin = 11.15% (FCF TTM 847.0m / Revenue TTM 7.60b)
Net Margin = 10.89% (Net Income TTM 827.0m / Revenue TTM 7.60b)
Gross Margin = 35.66% ((Revenue TTM 7.60b - Cost of Revenue TTM 4.89b) / Revenue TTM)
Gross Margin QoQ = 34.22% (prev 37.69%)
Tobins Q-Ratio = 2.93 (Enterprise Value 15.54b / Total Assets 5.31b)
Interest Expense / Debt = 0.79% (Interest Expense 25.0m / Debt 3.17b)
Taxrate = 27.54% (76.0m / 276.0m)
NOPAT = 679.7m (EBIT 938.0m * (1 - 27.54%))
Current Ratio = 1.88 (Total Current Assets 2.96b / Total Current Liabilities 1.58b)
Debt / Equity = -40.68 (negative equity) (Debt 3.17b / totalStockholderEquity, last quarter -78.0m)
Debt / EBITDA = 2.06 (Net Debt 2.61b / EBITDA 1.27b)
Debt / FCF = 3.09 (Net Debt 2.61b / FCF TTM 847.0m)
Total Stockholder Equity = -174.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.57% (Net Income 827.0m / Total Assets 5.31b)
RoE = -474.6% (negative equity) (Net Income TTM 827.0m / Total Stockholder Equity -174.2m)
RoCE = 33.85% (EBIT 938.0m / Capital Employed (Equity -174.2m + L.T.Debt 2.94b))
RoIC = 24.12% (NOPAT 679.7m / Invested Capital 2.82b)
WACC = 7.77% (E(12.93b)/V(16.10b) * Re(9.54%) + D(3.17b)/V(16.10b) * Rd(0.79%) * (1-Tc(0.28)))
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.95%
[DCF Debug] Terminal Value 74.08% ; FCFE base≈899.8m ; Y1≈959.5m ; Y5≈1.16b
Fair Price DCF = 75.13 (DCF Value 15.60b / Shares Outstanding 207.7m; 5y FCF grow 7.38% → 3.0% )
EPS Correlation: 35.94 | EPS CAGR: 10.37% | SUE: -0.66 | # QB: 0
Revenue Correlation: -59.89 | Revenue CAGR: -1.41% | SUE: -0.44 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.89 | Chg30d=-0.034 | Revisions Net=-3 | Analysts=17
EPS next Year (2026-12-31): EPS=4.22 | Chg30d=-0.127 | Revisions Net=-15 | Growth EPS=+7.4% | Growth Revenue=+2.9%
Additional Sources for MAS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle